High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta

American Journal of Physiology - Endocrinology and Metabolism

Volumn 305, Issue 2, 2013, Pages

  Visiedo, Francisco ^a   Bugatto, Fernando ^a   Sánchez, Viviana ^a   Cózar Castellano, Irene ^b   Bartha, Jose L ^a   Perdomo, Germán ^a,c  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Carnitine palmitoyltransferase I; De novo fatty acid synthesis; Esterification of fatty acids; Fatty acid oxidation; Gestational diabetes mellitus; Hyperglycemia; Placenta; Triglycerides

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE; ETOMOXIR; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MITOCHONDRION; PHOSPHORYLATION; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL;

CARNITINE PALMITOYLTRANSFERASE I; DE NOVO FATTY ACID SYNTHESIS; ESTERIFICATION OF FATTY ACIDS; FATTY ACID OXIDATION; GESTATIONAL DIABETES MELLITUS; HYPERGLYCEMIA; PLACENTA; TRIGLYCERIDES;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BLOTTING, WESTERN; CARNITINE O-PALMITOYLTRANSFERASE; CHOLESTEROL; CITRATE (SI)-SYNTHASE; DIABETES, GESTATIONAL; EPOXY COMPOUNDS; FATTY ACIDS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MITOCHONDRIA; ORGAN CULTURE TECHNIQUES; OXIDATION-REDUCTION; PLACENTA; PREGNANCY; TRIGLYCERIDES;

EID: 84880174455     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00032.2013     Document Type: Article

References (42)

1. No authors listed. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28: 1039-1057, 1979.
2. Bartha JL, Visiedo F, Fernandez-Deudero A, Bugatto F, Perdomo G. Decreased mitochondrial fatty acid oxidation in placentas from women with preeclampsia. Placenta 33: 132-134, 2012.
3. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
4. Brown NF. Expression, purification, and reconstitution of rat liver carnitine palmitoyltransferase I. Methods Mol Biol 228: 281-301, 2003.
5. Brown NF, Stefanovic-Racic M, Sipula IJ, Perdomo G. The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes. Metabolism 56: 1500-1507, 2007.
6. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 115: 485-491, 2005.
7. Bugatto F, Fernandez-Deudero A, Bailen A, Fernandez-Macias R, Hervias-Vivancos B, Bartha JL. Second-trimester amniotic fluid proinflammatory cytokine levels in normal and overweight women. Obstet Gynecol 115: 127-133, 2010.
8. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204: 479-487, 2011.
9. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28: 323-328, 2005.
10. Coltart TM, Bateman C. Carbohydrate-induced lipogenesis in the human placenta of normal and diabetic pregnancies. Br J Obstet Gynaecol 82: 471-475, 1975.
11. Corcoy R, Lumbreras B, Bartha JL, Ricart W; Grupo Español de Diabetes y Embarazo. [New diagnostic criteria for gestational diabetes mellitus after the HAPO study. Are they valid in our environment?] Endocrinol Nutr 57: 277-280, 2010.
12. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29: 274-281, 2008.
13. Dabelea D, Crume T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 60: 1849-1855, 2011.
14. Diamant YZ, Metzger BE, Freinkel N, Shafrir E. Placental lipid and glycogen content in human and experimental diabetes mellitus. Am J Obstet Gynecol 144: 5-11, 1982.
15. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes 29: 1023-1035, 1980.
16. Gauster M, Hiden U, van Poppel M, Frank S, Wadsack C, Hauguel-de Mouzon S, Desoye G. Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes 60: 2457-2464, 2011.
17. Göbl CS, Handisurya A, Klein K, Bozkurt L, Luger A, Bancher-Todesca D, Kautzky-Willer A. Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care 33: 2071-2073, 2010.
18. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58: 453-459, 2009.
19. HayWWJr. The placenta. Not just a conduit for maternal fuels. Diabetes 40, Suppl 2: 44-50, 1991.
20. Hosoya N, Hagerman D, Villee C. Stimulation of fatty acid synthesis by oestradiol in vitro. Biochem J 76: 297-301, 1960.
21. Hughes SD, Quaade C, Johnson JH, Ferber S, Newgard CB. Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucosestimulated insulin secretion. Relationship to glucose metabolism. J Biol Chem 268: 15205-15212, 1993.
22. Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T. Maternal serum triglyceride at 24-32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 97: 776-780, 2001.
23. Knopp RH, Bergelin RO, Wahl PW, Walden CE. Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes 34, Suppl 2: 71-77, 1985.
24. Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta 32: 121-127, 2011.
25. Lindegaard ML, Damm P, Mathiesen ER, Nielsen LB. Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression. J Lipid Res 47: 2581-2588, 2006.
26. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991-2002, 2008.
27. Mitanchez D. [Fetal and neonatal complications of gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal outcomes]. J Gynecol Obstet Biol Reprod (Paris) 39: S189-199, 2010.
28. Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabetes Care 18: 1550-1556, 1995.
29. Pathmaperuma AN, Mana P, Cheung SN, Kugathas K, Josiah A, Koina ME, Broomfield A, Delghingaro-Augusto V, Ellwood DA, Dahlstrom JE, Nolan CJ. Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose effect or interaction. Placenta 31: 230-239, 2010.
30. Pedersen J. The Pregnant Diabetic and Her Newborn: Problems and Management. Baltimore, MD: William & Willkins, 1967.
31. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 16: 330-342, 1954.
32. Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, Brown NF. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 279: 27177-27186, 2004.
33. Perdomo G, Kim DH, Zhang T, Qu S, Thomas EA, Toledo FG, Slusher S, Fan Y, Kelley DE, Dong HH. A role of apolipoprotein D in triglyceride metabolism. J Lipid Res 51: 1298-1311, 2010.
34. Radaelli T, Lepercq J, Varastehpour A, Basu S, Catalano PM, Hauguel-De Mouzon S. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol 201: 209. e201-209. e210, 2009.
35. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52: 2951-2958, 2003.
36. Roland JM, Murphy HR, Ball V, Northcote-Wright J, Temple RC. The pregnancies of women with Type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med 22: 1774-1777, 2005.
37. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 276: E1-E18, 1999.
38. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, Herrera E. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 31: 1858-1863, 2008.
39. Shafrir E, Khassis S. Maternal-fetal fat transport versus new fat synthesis in the pregnant diabetic rat. Diabetologia 22: 111-117, 1982.
40. Szabo AJ, Grimaldi RD. The effect of insulin on glucose metabolism of the incubated human placenta. Am J Obstet Gynecol 106: 75-78, 1970.
41. Szabo AJ, Szabo O. Placental free-fatty-acid transfer and fetal adiposetissue development: an explantation of fetal adiposity in infants of diabetic mothers. Lancet 2: 498-499, 1974.
42. Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory". Exp Diabetes Res 2011: 218598, 2011.